250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech Angel Investors in United States

A list of 50 angel investors that invest in Biotech startups based in United states. We rank investors based on the number of investments they made in Biotech companies from United states. We update this investor list every month.

Top 50 Biotech Angel Investors in United States

Investor Biotech United States investments
Milad Alucozai 14
Jaffray Woodriff 10
Jeff Dean 9
Kingsley Advani 9
bumpkins profile 8
Jude Gomila 8
Alice Zhang 7
Paul Buchheit 7
Zach Weinberg 6
Jeff Hammerbacher 6
Wei Guo 6
Chris Gibson 5
Erik Peterson 5
Kevin Moore 5
Evan Cheng 5
Jim Mellon 5
Farzad (Zod) Nazem 5
David R. Walt 4
Bill Gates 4
Sam Altman 4
Peter Thiel 4
David Beyer 4
Brian Armstrong 4
Timothy A. Springer 4
Sahin Boydas 4
Nat Turner 4
Mark Cuban 4
Anne Wojcicki 4
Ling Wong 4
Esther Dyson 4
Bill Gates 4
Daren Cotter 4
Eric Kwan 4
Brad Flora 4
John D'Orazio 4
Max Levchin 4
Elad Gil 4
Jack Abraham 4
Brenton Saunders 4
Bradley Horowitz 4
Cory Levy 4
Todd Corenson 4
Daniel Curran 4
Darian Shirazi 3
Kirill Makharinsky 3
Oleg Uritsky 3
Aaron Levie 3
Leonardo DiCaprio 3
Adrian Aoun 3
Rayyan Islam 3
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Milad Alucozai Angel · San Francisco, California, United States · 2 investments in the past 12 months
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Jaffray Woodriff Angel · Charlottesville, Virginia, United States
Angel Investor located in Charlottesville, VA
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Seed, Series A, Angel
  • United States
Portfolio highlights
  • Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
  • Fringe — With 100+ vendors, Fringe offers an employee lifestyle benefits experience that builds loyalty, productivity, and well-being. Learn more to get started!
  • Starchive — Built by creators for creators, to maximize the control and ownership of their media, community, and commerce in the Visual Economy.
Jeff Dean Angel · Palo Alto, California, United States · 8 investments in the past 12 months
Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a co­designer and co­implementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open­-source system for machine learning.​Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM­-Infosys Foundation Award in the Computing Sciences.
Show more
Investment focus
  • Artificial Intelligence, Biotechnology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom
Portfolio highlights
  • Luda — Lifting people through play
  • Elicit — Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers.
  • Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Kingsley Advani Angel · San Francisco, California, United States
Kingsley Advani is a British investor. He started investing in 2013, funding 50 companies, 4 funds and donating to non-profits including: SENS Foundation, Methuselah Foundation, Stanford University, National University of Singapore. He is particularly interested in regenerative medicine for age-related disease. Investments: Oisin, Turn Bio,Oncosenx, Monzo, Robinhood, Abra, Coinbase, Momentus, Demonpores, 64-x, Nectome. Investment areas: biotechnology, neurotechnology, longevity, space, fintech.
Show more
Investment focus
  • FinTech, Financial Services, Biotechnology
  • Seed, Pre-Seed, Series A
  • United States, Singapore, United Kingdom
Portfolio highlights
  • Checkstep — CheckStep provides a AI-powered Trust & Safety and UGC management software to online platform worldwide. It enables company to manage the full policy management life-cycle.
  • Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
  • Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
bumpkins profile Angel
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Pre-Seed
  • United States, Canada, India
Portfolio highlights
  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Jude Gomila Angel · San Francisco, California, United States · 4 investments in the past 12 months
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Angel
  • United States, United Kingdom, Canada
Portfolio highlights
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • Monitaur — Ship your crypto-powered products faster, safer, and more efficiently with AI-powered observability for Web3.
  • Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.
Alice Zhang Angel · San Francisco, California, United States
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom
Portfolio highlights
  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
Paul Buchheit Angel · Mountain View, California, United States · 4 investments in the past 12 months
Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Series A, Angel
  • United States, Canada, India
Portfolio highlights
  • SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
  • Character.ai — character.ai is bringing to life the science-fiction dream of open-ended conversations and collaborations with computers.
  • Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Zach Weinberg Angel · New York, New York, United States · 2 investments in the past 12 months
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, Israel, Colombia
Portfolio highlights
  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Jeff Hammerbacher Angel · 5 investments in the past 12 months
Jeff Hammerbacher - Partner & Co-Founder @ Techammer
Show more
Investment focus
  • Software, Artificial Intelligence, Biotechnology
  • Seed, Series A, Angel
  • United States
Portfolio highlights
  • Vectara — Put Generative AI into action with Vectara's end-to-end LLM pipeline, Grounded Generation, & APIs (Vectors, Hybrid Search, Summarization)
  • Modal Labs — Modal develops machine learning software to help run code in the cloud. The software enables users to run or deploy machine learning models, massively parallel compute jobs, task queues, web apps, and more. It also writes the code to launch hundreds of custom containers and runs scripts in the cloud faster than on the local machine.
  • Together — Together will enable researchers, developers & companies to leverage and improve artificial intelligence with an intuitive data, models & computation platform.
Wei Guo Angel · San Francisco, California, United States
Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.
Show more
Investment focus
  • Software, Artificial Intelligence, Health Care
  • Seed, Series A, Angel
  • United States, China, Canada
Portfolio highlights
  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
  • Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
  • Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.
Chris Gibson Angel · Salt Lake City, Utah, United States · 2 investments in the past 12 months
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more
Investment focus
  • Biotechnology, Pharmaceutical, Health Care
  • Series A, Seed
  • United States, France, United Kingdom
Portfolio highlights
  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Amenities — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Erik Peterson Angel · Chicago, Illinois, United States
Erik Peterson is the Founder at DormTrader.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Equity Crowdfunding, Series A
  • United States, Canada, Algeria
Portfolio highlights
  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.
Kevin Moore Angel · Dallas, Texas, United States · 2 investments in the past 12 months
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Pre-Seed, Angel
  • United States, India, Canada
Portfolio highlights
  • Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Augmend — AI-augmented knowledge transfer across developers through a platform that captures and shares expertise.
Evan Cheng Angel · Burlingame, California, United States
Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.
Show more
Investment focus
  • Software, Artificial Intelligence, Biotechnology
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Australia
Portfolio highlights
  • PARSIQ — Comprehensive tools for analyzing, detecting, and preventing cryptocurrency fraud.
  • Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
  • Kernal Biologics — Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA
Jim Mellon Angel · 3 investments in the past 12 months
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more
Investment focus
  • Biotechnology, Health Care, Food and Beverage
  • Series A, Seed, Funding Round
  • United States, United Kingdom, Israel
Portfolio highlights
  • Amy — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Farzad (Zod) Nazem Angel · Palo Alto, California, United States
Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.
Show more
Investment focus
  • Health Care, Analytics, Machine Learning
  • Seed, Series A, Series B
  • United States, Canada
Portfolio highlights
  • Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
  • Ceevra, Inc. — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
  • TigerGraph — TigerGraph is the fastest and only scalable graph database for the enterprise. Unleash the power and speed of our graph analytics platform today.
David R. Walt Angel · Boston, Massachusetts, United States
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
  • Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Bill Gates Angel · Washington, District of Columbia, United States · 5 investments in the past 12 months
Bill Gates is the founder, technology advisor, and board member of Microsoft Corporation, the worldwide leader in software, services, and solutions that help people and businesses realize their full potential. He served as chairman of the board until Feb. 4, 2014.On June 27, 2008, Gates transitioned out of a day-to-day role in the company tospend more time on his global health and education work at the Bill & Melinda Gates Foundation. He shares his thoughts about the foundation and other topics on Gates Notes, a website launched in January 2010. Gates continues to serve on Microsoft’s Board of Directors and as an advisor on key development projects. He is also the Founder of Breakthrough Energy.Born on Oct. 28, 1955, Gates grew up in Seattle with his two sisters. Their father, William H. Gates II, is a Seattle attorney. Their late mother, Mary Gates, was a schoolteacher, University of Washington regent, and chairwoman of United Way International.Gates attended public elementary school and the private Lakeside School. There, he discovered his interest in software and began programming computers at age 13.In 1973, Gates entered Harvard University as a freshman, where he lived down the hall from Steve Ballmer. While at Harvard, Gates developed a version of the programming language BASIC for the first microcomputer – the MITS Altair.In his junior year, Gates left Harvard to devote his energies to Microsoft, a company he had begun in 1975 with his childhood friend Paul Allen. Guided by a belief that the computer would be a valuable tool on every office desktop and in every home, they began developing software for personal computers. Gates’ foresight and his vision for personal computing have been central to the success of Microsoft and the software industry.Under Gates’ leadership, Microsoft’s mission has been to continually advance and improve software technology, and to make it easier, more cost-effective, and more enjoyable for people to use computers. The company is committed to a long-term view, reflected in its industry-leading investment in research and development each year.In 1999, Gates wrote Business @ the Speed of Thought, a book that shows how computer technology can solve business problems in fundamentally new ways. The book was published in 25 languages and is available in more than 60 countries. Business @ the Speed of Thought has received wide critical acclaim and was listed on the best-seller lists of the New York Times, USA Today, The Wall Street Journal, and Amazon.com. Gates’ previous book, The Road Ahead, published in 1995, was at the top of the New York Times bestseller list for seven weeks.Gates has donated the proceeds of both books to non-profit organizations that support the use of technology in education and skills development.In addition to his love of computers and software, Gates founded Corbis, which is developing one of the world’s largest resources of visual information – a comprehensive digital archive of art and photography from public and private collections around the globe. He is also a member of the board of directors of Berkshire Hathaway Inc., which invests in companies engaged in diverse business activities.Philanthropy is very important to Gates. He and his wife, Melinda, started a foundation in 2000 to help reduce inequities in the United States and around the world. The Bill & Melinda Gates Foundation supports philanthropic initiatives in the areas of global health and learning, with the hope that in the 21st century, advances in these critical areas will be available for all people. To learn more about the foundation, visit www.gatesfoundation.orgGates was married on Jan. 1, 1994, to Melinda French Gates. They have three children. Gates is an avid reader and enjoys playing golf, tennis, and bridge.
Show more
Investment focus
  • Energy, Biotechnology, Manufacturing
  • Series C, Series A, Series B
  • United States, Canada, Israel
Portfolio highlights
  • Mainspring Energy — Local power generation for the net-zero carbon grid.
  • Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
  • Inflection AI — We are an AI studio creating a personal AI for everyone.
Sam Altman Angel · San Francisco, California, United States · 20 investments in the past 12 months
Sam Altman is the co-founder and CEO of OpenAI. Sam was previously the Chairman of Y Combinator, a leading silicon valley startup accelerator.
Show more
Investment focus
  • Software, Internet, Artificial Intelligence
  • Seed, Series A, Series B
  • United States, Canada, Ghana
Portfolio highlights
  • Induced AI — Induced is an AI-native browser RPA platform that lets users combine browsing and web tools, along with smart reasoning and memory, to automate enterprise workflows of all kinds.
  • Slope — We handle the lending, underwriting, debt collection and fully pay out to you immediately once the product or service ships.
  • teachme.to — Teachme.to is a community of learners discovering lessons for everything.
Peter Thiel Angel · San Francisco, California, United States · 15 investments in the past 12 months
Peter Thiel Is The Member, Board of Directors At Facebook. Founder at Breakout Labs.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Series A, Seed, Series B
  • United States, Germany, Canada
Portfolio highlights
  • Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
  • Alias Technologies — Here at Alias Technologies our goal is to help organizations tackle complex IT goals and initiatives in an ever-changing landscape. Leveraging our Partner relationships and extensive experience we are able to help position our customers for the future.
  • Treasure Financial — An automated cash flow tool for businesses and startups. Get started today, all you need is 15 minutes to maximize your existing cash.
David Beyer Angel · San Francisco, California, United States
David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.
Show more
Investment focus
  • Software, Artificial Intelligence, Enterprise Software
  • Seed, Series A, Angel
  • United States
Portfolio highlights
  • Airtable — Airtable is a cloud-based software company that offers an easy-to-use online platform for creating and sharing relational databases.It brings the database out of the realm of power users and into the mainstream, creating a new type of flexible but sophisticated productivity tool that anyone can use. Airtable gives end-users the ability to createand share their own workflows for everything from managing an editorial calendar to planning a major event. The platform helps create flexible checklists, organize collections or ideas, and manage customers or contacts as well as offers a variety of templates ranging from home improvement to store inventory, enabling users to build custom applications without any prior coding experience.The company was founded by Andrew Ofstad, Emmett Nicholas, and Howie Liu in 2013 and is headquartered in San Francisco, California.
  • Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
  • Ginkgo Bioworks — Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria toprotect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.
Brian Armstrong Angel · San Francisco, California, United States
Brian Armstrong is the CEO and Co-founder of Coinbase, the world’s leading digital currency exchange. As CEO, Mr. Armstrong is responsible for Coinbase’s retail and institutional arms and all products and services that are developed by both trading platforms. Mr. Armstrong co-founded Coinbase in June 2012, and since then, has been responsible forintroducing much of America and beyond to cryptocurrency. Mr. Armstrong has led the team, now at over 200 employees, through over $200M in funding from leading investors such as Andreessen Horowitz, IVP, USV, DFJ and NYSE. Since co-founding the company, Mr. Armstrong has led Coinbase to serve over 10M customers across 32 countries, providing custody for more than $10B in digital assets. Mr. Armstrong was listed as Fortune 40 under 40 and Recode 100 in 2017.Before founding Coinbase, Mr. Armstrong worked as a Software Engineer at Airbnb from 2011-2012 as part of the hospitality marketplace, focusing on fraud prevention. At the time, Airbnb was moving money between 190 countries, and Mr. Armstrong had a front row seat into global payment systems.Previously, he worked as a Developer for IBM and Consultant at Deloitte.Mr. Armstrong holds three degrees from Rice University: Bachelor’s of Computer Science, Bachelor’s of Economics, and a Master’s of Computer Science.
Show more
Investment focus
  • Payments, Financial Services, Banking
  • Seed, Series A, Series B
  • United States, Brazil
Portfolio highlights
  • Binti — Foster Care Software
  • Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
  • Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Timothy A. Springer Angel · Cambridge, Massachusetts, United States
Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series A, Series B, Seed
  • United States, Canada
Portfolio highlights
  • Prenuvo — Prenuvo offers MRI scanning systems that help in early detection of cancer and other diseases.
  • Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
  • Tectonic Therapeutic — Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).
Sahin Boydas Angel · San Francisco Bay Area, California, United States · 12 investments in the past 12 months
Sahin Boydas is the Head of RemoteTeam at Gusto.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Series A, Seed, Series B
  • United States, Mexico, Spain
Portfolio highlights
  • Postman — Postman is a complete API development environment, used by nearly six million developers and more than 200,000 companies worldwide. It offers a platform for developers or enterprises to build, test, and debug their APIs. The platform intends to use the funds to continue to expand operations and its business reach.Postman is an elegant, flexibletool used to build connected software via APIs quickly, easily, and accurately. It enables API-first development, automated testing, and developer onboarding. The platform's features simplify each step of building an API and streamline collaboration so they can create better APIs faster. Postman was founded in 2014 and is headquartered in San Francisco and has an office in Bangalore, where it was founded. Postman is privately held, with funding from Nexus Venture Partners.
  • Owner — Save Money By Converting Third Party Orders To Order Through Your Website. Build Your Customer Database. Increase Sales With Automatic Text and Email Marketing. Setup For You. Built In Loyalty.
  • Shield AI — AI pilots will revolutionize battlefields and commercial aviation at a scale greater than the self-driving movement reshaping our highways.
Nat Turner Angel · New York, New York, United States
Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, China, Colombia
Portfolio highlights
  • CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
  • Collectors — Helping collectors to pursue their passion.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Mark Cuban Angel · Dallas, Texas, United States · 13 investments in the past 12 months
Mark Cuban is the founder of Fireside, Chairman and Founding partner of AXS TV, and the Owner of Dallas Mavericks. Prior to that, he was the Co-Founder of Broadcast.com. Mrk attended the Indiana University Bloomington.
Show more
Investment focus
  • Software, Artificial Intelligence, Blockchain
  • Seed, Series A, Angel
  • United States, United Kingdom, Singapore
Portfolio highlights
  • Bot-It — Online automation for everyone. Let Bot-It automatically complete your online tasks.
  • Glove Wrap — Glove Wrap is a latex-free, thermoplastic elastomer band with the precise thickness, width, and length required to break in and shape your complete baseball glove while making the ideal pocket. Wrapping your glove with Glove Wrap applies pressure to the glove, reshaping it for easy use.
  • Regent — We build all-electric, passenger-carrying, wing-in-ground-effect vehicles to service coastal routes with technology available today.
Anne Wojcicki Angel · San Francisco, California, United States · 7 investments in the past 12 months
Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Series B
  • United States, United Kingdom, Canada
Portfolio highlights
  • Calypso AI — CalypsoAI combines industry-leading AI testing and human-in-the-loop decision making to give you the confidence you need to push AI projects into production.
  • Eureka Health — Helping people with chronic conditions mitigate their symptoms.
  • Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
Ling Wong Angel · Seattle, Washington, United States
Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States
Portfolio highlights
  • Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
  • Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
  • Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.
Esther Dyson Angel · New York, New York, United States
Esther Dyson - Founder @ Way to Wellville
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Funding Round
  • United States, Canada, Russian Federation
Portfolio highlights
  • Boxhub — Buy new & used shipping containers with Boxhub. We make buying a shipping container easy & deliver it right to your door. Buy a storage container today!
  • Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
  • Humanity — Slow down, or even, reverse your aging.
Bill Gates Angel · Seattle, Washington, United States · 2 investments in the past 12 months
Bill Gates is the founder, technology advisor, and board member of Microsoft Corporation, the worldwide leader in software, services, and solutions that help people and businesses realize their full potential. He served as chairman of the board until Feb. 4, 2014.On June 27, 2008, Gates transitioned out of a day-to-day role in the company tospend more time on his global health and education work at the Bill & Melinda Gates Foundation. He shares his thoughts about the foundation and other topics on Gates Notes, a website launched in January 2010. Gates continues to serve on Microsoft’s Board of Directors and as an advisor on key development projects. He is also the Founder of Breakthrough Energy.Born on Oct. 28, 1955, Gates grew up in Seattle with his two sisters. Their father, William H. Gates II, is a Seattle attorney. Their late mother, Mary Gates, was a schoolteacher, University of Washington regent, and chairwoman of United Way International.Gates attended public elementary school and the private Lakeside School. There, he discovered his interest in software and began programming computers at age 13.In 1973, Gates entered Harvard University as a freshman, where he lived down the hall from Steve Ballmer. While at Harvard, Gates developed a version of the programming language BASIC for the first microcomputer – the MITS Altair.In his junior year, Gates left Harvard to devote his energies to Microsoft, a company he had begun in 1975 with his childhood friend Paul Allen. Guided by a belief that the computer would be a valuable tool on every office desktop and in every home, they began developing software for personal computers. Gates’ foresight and his vision for personal computing have been central to the success of Microsoft and the software industry.Under Gates’ leadership, Microsoft’s mission has been to continually advance and improve software technology, and to make it easier, more cost-effective, and more enjoyable for people to use computers. The company is committed to a long-term view, reflected in its industry-leading investment in research and development each year.In 1999, Gates wrote Business @ the Speed of Thought, a book that shows how computer technology can solve business problems in fundamentally new ways. The book was published in 25 languages and is available in more than 60 countries. Business @ the Speed of Thought has received wide critical acclaim and was listed on the best-seller lists of the New York Times, USA Today, The Wall Street Journal, and Amazon.com. Gates’ previous book, The Road Ahead, published in 1995, was at the top of the New York Times bestseller list for seven weeks.Gates has donated the proceeds of both books to non-profit organizations that support the use of technology in education and skills development.In addition to his love of computers and software, Gates founded Corbis, which is developing one of the world’s largest resources of visual information – a comprehensive digital archive of art and photography from public and private collections around the globe. He is also a member of the board of directors of Berkshire Hathaway Inc., which invests in companies engaged in diverse business activities.Philanthropy is very important to Gates. He and his wife, Melinda, started a foundation in 2000 to help reduce inequities in the United States and around the world. The Bill & Melinda Gates Foundation supports philanthropic initiatives in the areas of global health and learning, with the hope that in the 21st century, advances in these critical areas will be available for all people. To learn more about the foundation, visit www.gatesfoundation.orgGates was married on Jan. 1, 1994, to Melinda French Gates. They have three children. Gates is an avid reader and enjoys playing golf, tennis, and bridge.
Show more
Investment focus
  • Energy, Biotechnology, Manufacturing
  • Series A, Series C, Series B
  • United States, Canada, Israel
Portfolio highlights
  • Mainspring Energy — Local power generation for the net-zero carbon grid.
  • Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
  • Inflection AI — We are an AI studio creating a personal AI for everyone.
Daren Cotter Angel · Minneapolis, Minnesota, United States · 3 investments in the past 12 months
Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Seed, Series A, Funding Round
  • United States
Portfolio highlights
  • TicketRev — TicketRev helps fans find cheaper tickets to their favorite games and concerts. Fans name their price for their preferred seating location, enabling resellers and teams to sell their inventory faster.
  • Fulcrum — Designed with technology in mind, be free of paper with Fulcrum, the manufacturing ERP of the future. Ai scheduling, visual BOM, live tracking
  • Vertical Insure — Vertical Insure is an insurance company built for vertical SaaS platforms.
Eric Kwan Angel · San Francisco, California, United States
Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures
Show more
Investment focus
  • Software, FinTech, E-Commerce
  • Seed, Pre-Seed, Funding Round
  • United States, India, Canada
Portfolio highlights
  • Treinta — Treinta is a digital ledger app for Latin American microbusinesses. Through Treinta, users can easily record transactions by assigning products from their inventory and see how their business metrics evolve in real time. The app helps owners save up to 30 minutes a day in bookkeeping related tasks and improve efficiency by over 30%. Out of the 50million microbusinesses in LATAM, today 90% still track their sales and expenses by using pen and paper.
  • Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
  • Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot
Brad Flora Angel · San Francisco, California, United States
Brad Flora is a Visiting Partner at Y Combinator. He is a former Co-Founder and CEO of Perfect Audience. Mr. Flora received a BA from Princeton University in English and an MS in Journalism from Northwestern.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Pre-Seed, Series A
  • United States, Mexico, India
Portfolio highlights
  • SWAP — Swap empowers companies to transform their financial operation with an innovative approach, technology, and business model. SWAP’s APIs offer clients end-to-end, white-label, financial solutions. Connected to them, its clients are able to develop complete financial ecosystems including pre-paid cards, digital wallets, financial services and furthermonetize their platform while expanding their core experience. It removes barriers and generates new business lines for companies, effectively creating internal fintech.
  • Wallet.ng — Wallet.ng is a fintech startup that allows people and companies to send, receive, and make payments, using their phone numbers.The company's infrastructure also provides plugins and libraries for merchants to accept payments online with just a URL. Wallet.ng users can pay directly into bank accounts and Pay Utility Bills in Nigeria.Wallet.ng is a mobile payment solution, its core infrastructure is built using technologies which is adaptable for multiple countries across Africa.It was established in Lagos, Lagos by John Oluranti Oke and Joseph Benson-Aruna in 2018..
  • Wallets — Wallets Africa helps Africans and African-owned businesses send money, receive money, make card payments, and access overdrafts.
John D'Orazio Angel · New York, New York, United States
John is the Founder and CEO of Capture Collective.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Equity Crowdfunding
  • United States
Portfolio highlights
  • RenovoDerm — A medical device company building a line of wound care products that provide a structure for tissue growth and promote faster healing of wounds—while reducing scar tissue. Funding prior to formation: $1.6 million.
  • Vascular Genesis — A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products -- with self-healing capabilities that lower the risk of rejection, infection, and stenosis. Funding prior to formation: $2.5 million.
  • Atreon Orthopedics — A medical device company building a line of orthopedic products that provide a structure for tissue growth and healing of sports medicine injuries including tendon ruptures/tears.
Max Levchin Angel · San Francisco, California, United States · 2 investments in the past 12 months
Max Levchin is an investor and advisor to emerging technology companies. He was previously the chairman and chief executive officer of HVF, a startup lab focused on extracting insights from recordable information.Levchin co-founded Confinity Inc. in December 1998, and served as the Chief Technology Officer and a director. He also foundedNetMeridian Software, a developer of early Internet applications Levchin also serves as chairman of the boards of directors of Yelp Inc. and Kaggle Inc., and as a director of Evernote Corporation.
Show more
Investment focus
  • FinTech, Financial Services, Mobile
  • Series A, Seed, Series B
  • United States, United Kingdom, India
Portfolio highlights
  • withco — You deserve to own your business' real estate. We make it happen. Apply in 5 min to see if our lease-to-own partnership is right for you.
  • Pomelo — At Pomelo we build state-of-the-art fintech infrastructure. Our technology enables you to launch and scale your financial services business.
  • CoPilot — CoPilot is pioneering Assisted Commerce for big-ticket purchases – starting with cars. You are the one spending the money - shouldn't you have an expert on your side? We founded CoPilot to make that a reality. For the average car buyer, who is not a car expert or enthusiast, car shopping can be a time consuming, frustrating process that leavespeople feeling alone and disadvantaged. CoPilot is changing this dynamic. Like a trusted friend who is knowledgeable about cars, knows where to look and what to buy, CoPilot provides car shoppers with an expert partner who empowers them to discover the perfect car at the best possible price with ease and confidence.
Elad Gil Angel · San Francisco, California, United States · 21 investments in the past 12 months
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Series B
  • United States, United Kingdom, Israel
Portfolio highlights
  • Modal Labs — Modal develops machine learning software to help run code in the cloud. The software enables users to run or deploy machine learning models, massively parallel compute jobs, task queues, web apps, and more. It also writes the code to launch hundreds of custom containers and runs scripts in the cloud faster than on the local machine.
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
  • Neon — Postgres made for developers. Easy to Use, Scalable, Cost efficient solution for your next project.
Jack Abraham Angel · San Francisco, California, United States · 3 investments in the past 12 months
Jack is the Founder and Managing Partner of Atomic, a venture studio that is investing out of its second $150M fund that has co-founded over a dozen companies.  Atomic and its companies have raised over $550M over the past several years.  Jack is also an angel investor in companies such as Uber, Pinterest, Flatiron Health and Postmates which heoriginally gave the founders the idea of.  Previously Jack founded Milo.com, a local shopping search engine that was acquired by Ebay for $75M.Jack also serves as the executive director of the Thiel Fellowship.
Show more
Investment focus
  • Health Care, Biotechnology, Fitness
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • OneAdvisory — OneAdvisory helps independent financial advisors to build ideal firms through strategic investments and advanced technology. The company was founded in 2022 and is headquartered in Miami, Florida.
  • Wally Health — Unlimited dental cleanings and whitening for $199/year
  • NUE Life Health — NUE Life aims to improve mental wellness by enhancing brain function, performance, and longevity through evidence based and scientifically proven mental health treatments and products.
Brenton Saunders Angel · Parsippany, New Jersey, United States
Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • Wondermind — Welcome to Wondermind, your home for approachable, expert-backed mental health content you can actually use.
  • Nucleus — Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
  • Lipidio Pharmaceuticals — Lipidio Pharmaceuticals is a healthcare company that focuses on advancing a molecule to treat diseases associated with excess body fat. It includes non-alcoholic steatohepatitis, Prader-Willi syndrome, and antipsychotic drug-induced weight gain. The company was founded in 2018 and headquartered in San Diego, California.
Bradley Horowitz Angel · Palo Alto, California, United States · 5 investments in the past 12 months
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom, Germany
Portfolio highlights
  • Vectara — Put Generative AI into action with Vectara's end-to-end LLM pipeline, Grounded Generation, & APIs (Vectors, Hybrid Search, Summarization)
  • CUR8 — Even if we do everything else right on reducing emissions, the world still needs to remove up to 220 Gigatonnes of carbon from the atmosphere by 2050
  • Mill — So long, smelly bags. Goodbye, greenhouse gasses. Reserve your membership today and make a real difference from your kitchen.
Cory Levy Angel · San Francisco, California, United States · 10 investments in the past 12 months
Cory Levy is the Founder Advisor of Humaning.
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Pre-Seed, Seed, Grant
  • United States, United Kingdom
Portfolio highlights
  • Swsh — Swsh is a social app that aims to strengthen true friendships rather than superficial relationships with followers.
  • Eversify Labs — Eversify is a blockchain analytics and order-aggregation platform that allows investors to directly transact assets from any exchange. Crypto investors can use Eversify to manage their portfolios, conduct due diligence, and view data for blockchain assets in real-time.
  • Induced AI — Induced is an AI-native browser RPA platform that lets users combine browsing and web tools, along with smart reasoning and memory, to automate enterprise workflows of all kinds.
Todd Corenson Angel · Los Gatos, California, United States
Todd Corenson - Founder @ Enlon
Show more
Investment focus
  • Biotechnology, FinTech, Software
  • Seed, Pre-Seed, Convertible Note
  • United States
Portfolio highlights
  • Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
  • HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
  • iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.
Daniel Curran Angel · San Francisco, California, United States
Daniel Curran is the Founder and CEO at CustEx.com.
Show more
Investment focus
  • E-Commerce, Software, Mobile
  • Seed, Series A, Funding Round
  • United States, Brazil, Canada
Portfolio highlights
  • CARD.com — Fully featured bank account with optional overdraft protection and round up savings account. Get your paycheck up to 2 days earlier.
  • RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
  • GC Plus — Find Your Next Home Service Expert With Ease
Darian Shirazi Angel · San Francisco, California, United States · 20 investments in the past 12 months
Darian Shirazi is the General Partner of Gradient Ventures.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Series A, Series B
  • United States, Germany, Canada
Portfolio highlights
  • Resend — Build, test, and send transactional emails at scale.
  • Infisical — Infisical is an open-source, end-to-end encrypted tool that supports developers in managing their teams, devices, and infrastructure's secrets and environment variables. Using an end-to-end encrypted method, it avoids the leakage of confidential information to version control and over insecure channels like email.
  • Alongside — Alongside builds indexes for cryptocurrencies.
Kirill Makharinsky Angel · San Francisco, California, United States
Kirill is the CEO and Founder of Enki, a tech-enabled skills training company.Previously, Kirill cofounded Emerging Travel, a leading online travel agency; and Quid, an intelligence tool for strategy teams. Both companies have over $40M annual net revenue each.Kirill is an Oxford University alum where he graduated with a double first inMathematics and as the #1 UK Graduate of the Year.
Show more
Investment focus
  • Health Care, Apps, Mobile
  • Seed, Angel
  • United States, United Kingdom
Portfolio highlights
  • Calm — Relax with Calm, a simple mindfulness meditation app that brings clarity and peace of mind into your life
  • Togethera — We're bringing the world’s families closer together by providing a private, simple place to share, that’s easily accessible by grandparents and children, on phones, tablets and computers.
  • Share Practice — Share Practice helps doctors identify and understand the most effective clinical treatments based on the success of other doctors.
Oleg Uritsky Angel · Boston, Massachusetts, United States
Oleg Uritsky - Founder & CEO @ Helge Capital, Inc.
Show more
Investment focus
  • Biotechnology, Medical Device, Health Care
  • Seed, Series A, Funding Round
  • United States
Portfolio highlights
  • Skulpt — Skulpt changes how fitness is measured by tracking when your losing fat and gaining muscle for up to 24 individual muscles as well as your total body.
  • Corbus Pharmaceuticals — Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of endocannabinoid system-targeting synthetic drug candidates. The Company's lead product candidate, lenabasum, isa novel, synthetic, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.Corbus is also developing a pipeline of drug candidates from more than 600 novel compounds targeting the endocannabinoid system. The pipeline includes CRB-4001, a 2nd generation, peripherally-restricted, selective cannabinoid receptor type 1 (CB1) inverse agonist. Potential indications for CRB-4001 include NASH, among others. Corbus plans to start a Phase 1 study of CRB-4001 in 2019, intended to be followed by a National Institutes of Health (NIH)-funded proof-of-concept Phase 2 study.
  • SeniorQuote Insurance Services
Aaron Levie Angel · San Francisco Bay Area, California, United States · 2 investments in the past 12 months
Aaron Levie is Chief Executive Officer, Cofounder and Chairman at Box, which he launched in 2005 with CFO and cofounder Dylan Smith. He is the visionary behind the Box product and platform strategy, incorporating the best of secure content collaboration with an intuitive user experience suited to the way people work today. Aaron leads the companyin its mission to transform the way people and businesses work so they can achieve their greatest ambitions. He has served on the Board of Directors since April 2005.Aaron attended the University of Southern California from 2003 to 2005 before leaving to found Box.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
  • BoomPop — Work culture resources, virtual event inspiration, team building ideas, and fresh perspectives on the future work, brought to you by the BoomPop team.
  • Superblocks — Superblocks is the fast, easy and secure way for developers to build custom internal tools fast. Connect your databases & APIs. Drag and drop UI components. Extend with Python or Javascript. Deploy in 1-click. Secure and Monitor using your favorite tools
Leonardo DiCaprio Angel · Los Angeles, California, United States
Leonardo DiCaprio is an American actor and film producer. He has been nominated for three Academy Awards and nine Golden Globe Awards. He won the Golden Globe Award for Best Actor for his performance in The Aviator (2004), and has been nominated by the Screen Actors Guild, Satellite Awards, and the British Academy of Film and Television Arts. Acommitted environmentalist, DiCaprio has received praise from environmental groups for his activism. At the 2007 Oscar ceremony, DiCaprio and former Vice President Al Gore announced that the Academy Awards had incorporated environmentally intelligent practices throughout the planning and production processes, and on July 7, 2007, DiCaprio presented at the American leg of Live Earth.
Show more
Investment focus
  • Food and Beverage, Food Processing, Health Care
  • Series A, Funding Round, Series B
  • United States, Israel, United Kingdom
Portfolio highlights
  • LOCI — LOCI is an online shop that offers products for men and women. It was founded in the year of 2019, and the headquarter is in London, United Kingdom.
  • VitroLabs — The world's oldest material made new. VitroLabs Inc is a startup developing lab grown leather, through tissue engineering, as a solution to help fight climate change. All, while completely avoiding animal slaughter.
  • Neat Burger — Neat Burger is a planet-friendly plant-based full-flavoured game-changer that the world has been waiting for.
Adrian Aoun Angel · San Francisco, California, United States · 2 investments in the past 12 months
Adrian Aoun is the founder and CEO of Forward, an AI-based healthcare system combining world-class private doctors with new technology to enable proactive, data-driven primary care. Most recently, he was the head of Special Projects for the CEO of Google/Alphabet, where he founded one of the Alphabet companies Sidewalk Labs. Adrian arrivedat Google upon the acquisition of his AI startup Wavii, and spent his first year at Google helping to create and build their AI division. Additionally, Adrian is an active angel investor and advisor to a number of technology startups and funds.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Series B
  • United States, India, Germany
Portfolio highlights
  • Mojocare — Mojocare is a digital-first judgement-free wellness platform.
  • Range — Experience all-in-one wealth management from Range. Access wealth management services from our team of Certified Financial Planners and unified financial management through one thoughtfully designed platform. Learn more about becoming a member.
  • ShareWell — Struggling with mental health issues? ShareWell provides online peer support, a proven mental health alternative for therapy. Get group support when you need it.
Rayyan Islam Angel · Los Angeles, California, United States
Rayyan Islam is the Co-Founder and General Partner at 8090 Industries. As serial entrepreneur, investor and advisor focused on industrial technology and the low-carbon economy, the companies Rayyan's invested in, sourced and advised have grown to over $8B in market value and have gone to raise further financing from the likes of SequoiaCapital, Union Square Ventures, Lux Capital, Andreessen Horowitz, Venrock, Khosla Ventures and Bill Gates's Breakthrough Energy Ventures. Rayyan previously spent time helping source technology investments for multiple family offices globally, particularly focused towards industrialists based in the Texas and American midwest region and began his VC career at leading East Coast seed stage venture firm, Romulus Capital, where he sourced the firm’s most valued investment, EquipmentShare.A product manager by trade, he worked stints at Spotify, was on the founding team of a subscription airline and began his career supporting M&A transactions for industrial clients at Deloitte as well as economic developments efforts for Deloitte Consulting’s Emerging Markets Practice. Rayyan is a Forbes 30U30 Fellow, served as a United Nations Youth Delegate and is a recipient of the Outstanding Youth Delegate Award.Influenced by his family upbringing in Bangladesh, he personally witnessed energy security issues and the ramifications of climate change at a young age and its impact on communities around the world. Determined to make a serious dent on the issue, Rayyan supports a cadre of climate solutions, drafted policy recommendations to President Joe Biden’s climate transition team and is the editor of Decarbon Weekly, a decarbonization focused newsletter which counts leading climate scientists, members of state and local governments, climate tech founders and ESG focused investors and foundations amongst its subscription base. Rayyan co-founded the industrial decarbonization fund at 8090 Partners, in partnership with prominent industrial and energy families from around the world to invest, support and accelerate breakthrough technology companies decarbonizing every industrial sector driven by radical economic advantages.Rayyan and his work has been featured on Bloomberg, Yahoo Finance, Huffington Post and Forbes.
Show more
Investment focus
  • Renewable Energy, Biotechnology, Energy
  • Seed, Series A, Funding Round
  • United States, France, Switzerland
Portfolio highlights
  • Pipe — Get up to the full annual value of your booked monthly and quarterly contracts. Scale your business without dilution or debt.
  • Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
  • Renaissance Fusion — Renaissance Fusion is a high-temperature superconductor and stellarator company.
Investors by industry
Investors by country
Angel Investors in United States by industry